News | January 20, 2015

Veran Medical Completes $12 Million in Financing For Lung Cancer System

Funds to support commercial expansion in the U.S. and international launch of the Thoracic Navigation System

Lung cancer, Biopsy System, Thoracic Navigation System

Image courtesy of Veran Medical

January 20, 2015 — Veran Medical Technologies announced the completion of a $12 million financing to support the company's continued commercial expansion in the United States and international launch of the Veran Thoracic Navigation System.

Jason Pesterfield, president and CEO of Veran Medical Technologies comments: "The development of a Thoracic Navigation System that combines electromagnetic navigation bronchoscopy (ENB) and the Veran SPiNPerc navigated percutaneous lung biopsy procedure, enables physicians to biopsy lung nodules whether they are inside or outside the airways with a single system in one procedure."

Lung cancer causes more deaths in men and women than colon, breast and prostate cancer combined. If lung cancer is diagnosed at Stage III or IV, the five-year survival rate is only 15 percent. With early detection, there can be an 88 percent survival rate at 10 years and a 92 percent survival rate with the immediate removal of the lesion. Prior to the development of Veran's Thoracic Navigation System, only 16 percent of lung cancer patients have been diagnosed at an early stage 3.

For more information:

Related Content

Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
NEST Program Names ACR Data Science Institute AI Use Case as Demonstration Project
News | Artificial Intelligence | February 07, 2018
A U.S. Food and Drug Administration (FDA)-funded program to speed safe and effective medical device technologies to...
Small-Cell Lung Cancer Patients Face Barriers to Standard-of-Care Treatment
News | Lung Cancer | January 29, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the...
Age Impacts Post-treatment Mortality for Early-stage Lung Cancer Patients

Image courtesy of Henri Becquerel Cancer Center

News | Stereotactic Body Radiation Therapy (SBRT) | January 24, 2018
A University of Colorado Cancer Center study published in the Journal of Clinical Oncology explores mortality in the...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs. Dave Fornell
News | Lung Cancer | December 22, 2017
Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City...
Mirada Medical and Optellum Debut AI-Based Lung Cancer Diagnosis Solution at RSNA 2017
News | Computed Tomography (CT) | December 14, 2017
Optellum, a high-tech startup in lung cancer and machine learning, and Mirada Medical recently announced a partnership...
Integration of Smoking Cessation Within CT Lung Cancer Screenings Shows Life-Saving Results
News | Lung Cancer | October 26, 2017
A study that integrated robust smoking cessation programs into an organized low-dose computed tomography (LDCT) lung...
Overlay Init